Department of Respiratory and Critical Medicine of Beijing An Zhen Hospital, Capital Medical University, Beijing, China; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.
Am J Cardiol. 2019 Feb 15;123(4):632-637. doi: 10.1016/j.amjcard.2018.11.014. Epub 2018 Nov 24.
Periodic limb movements in sleep (PLMS) are associated with adverse outcomes in patients with heart failure (HF). The aim of this study was to investigate whether PLMS change in response to adaptive servo-ventilation (ASV) for central sleep apnea (CSA) in patients with HF. We examined polysomnographic studies conducted between 2010 and 2014 at Mayo Clinic, Rochester, Minnesota (n = 14,444). In those, 314 of 579 patients with CSA completed the sleep study with a protocol that began with diagnostic polysomnography, followed by continuous positive airway pressure, and, for persistent CSA, by ASV titration. Patients with HF (n = 118) had a significantly higher median PLM index compared with those without HF (n = 196): 33.7 versus 6.1 events/h (p <0.001). HF was associated with a significant PLM arousal index (PLMAI) increase from diagnostic trial to ASV (odds ratio [OR] = 1.79, p = 0.032) after adjusting for demographics, co-morbidities and medications. In patients aged >68 years, HF was associated with PLMI and PLMAI increases during ASV (OR = 2.16, p = 0.016 and OR = 2.05, p = 0.024), which persisted in multivariable models (OR = 2.36, p = 0.025 and OR = 2.33, p = 0.026). In multivariable analysis, patients with ejection fraction ≤45% had higher odds of increased PLMAI during ASV than those with ejection fraction >45% (OR = 1.98, p = 0.022). In conclusion, PLMS may increase in HF patients after suppression of CSA by ASV. Whereas the clinical significance of increased post-ASV PLMS in HF prognosis needs to be determined, these increases may contribute to worsening outcomes in HF patients with CSA treated with ASV.
周期性肢体运动在睡眠中(PLMS)与心力衰竭(HF)患者的不良预后相关。本研究旨在探讨 PLMS 是否会因自适应伺服通气(ASV)治疗中枢性睡眠呼吸暂停(CSA)而发生变化。我们检查了 2010 年至 2014 年在明尼苏达州罗切斯特市梅奥诊所进行的多导睡眠图研究(n=14444)。在这些患者中,579 例 CSA 患者中有 314 例完成了睡眠研究,该研究方案从诊断性多导睡眠图开始,随后是持续气道正压通气,对于持续 CSA,则进行 ASV 滴定。HF 患者(n=118)的 PLM 指数中位数明显高于无 HF 患者(n=196):33.7 比 6.1 事件/小时(p<0.001)。HF 与诊断试验至 ASV 期间 PLMAI 显著增加相关(调整人口统计学、合并症和药物后比值比[OR] =1.79,p=0.032)。在年龄>68 岁的患者中,HF 与 ASV 期间 PLMI 和 PLMAI 增加相关(OR=2.16,p=0.016 和 OR=2.05,p=0.024),在多变量模型中仍存在相关性(OR=2.36,p=0.025 和 OR=2.33,p=0.026)。在多变量分析中,射血分数≤45%的患者比射血分数>45%的患者在 ASV 期间发生 PLMAI 增加的可能性更高(OR=1.98,p=0.022)。总之,HF 患者 CSA 被 ASV 抑制后,PLMS 可能会增加。尽管需要确定 ASV 治疗 CSA 的 HF 预后中增加的 PLMS 的临床意义,但这些增加可能会导致接受 ASV 治疗的 HF 合并 CSA 患者的预后恶化。